Drug-induced nephrolithiasis is a rare condition in children. The involved drugs may be divided into two different categories according to the mechanism involved in calculi formation. The first one includes poorly soluble drugs that favor the crystallization and calculi formation. The second category includes drugs that enhance calculi formation through their metabolic effects. The diagnosis of these specific calculi depends on a detailed medical history, associated comorbidities and the patient's history of drug consumption. There are several risk factors associated with drug-induced stones, such as high dose of consumed drugs and long duration of treatment. Moreover, there are some specific risk factors, including urinary pH and the amount of fluid consumed by children. There are limited data regarding pediatric lithogenic drugs, and hence, our aim was to perform a comprehensive review of the literature to summarize these drugs and identify the possible mechanisms involved in calculi formation and discuss the management and preventive measures for these calculi.

Drug-Induced Urolithiasis in Pediatric Patients / M.C. Sighinolfi, A. Eissa, L. Bevilacqua, A. Zoeir, S. Ciarlariello, E. Morini, S. Puliatti, V. Durante, P.L. Ceccarelli, S. Micali, G. Bianchi, B. Rocco. - In: PAEDIATRIC DRUGS. - ISSN 1174-5878. - 21:5(2019), pp. 323-344. [10.1007/s40272-019-00355-5]

Drug-Induced Urolithiasis in Pediatric Patients

B. Rocco
2019

Abstract

Drug-induced nephrolithiasis is a rare condition in children. The involved drugs may be divided into two different categories according to the mechanism involved in calculi formation. The first one includes poorly soluble drugs that favor the crystallization and calculi formation. The second category includes drugs that enhance calculi formation through their metabolic effects. The diagnosis of these specific calculi depends on a detailed medical history, associated comorbidities and the patient's history of drug consumption. There are several risk factors associated with drug-induced stones, such as high dose of consumed drugs and long duration of treatment. Moreover, there are some specific risk factors, including urinary pH and the amount of fluid consumed by children. There are limited data regarding pediatric lithogenic drugs, and hence, our aim was to perform a comprehensive review of the literature to summarize these drugs and identify the possible mechanisms involved in calculi formation and discuss the management and preventive measures for these calculi.
Adolescent; Adult; Child; Child; Preschool; Humans; Infant; Infant; Newborn; Kidney Calculi; Risk Factors; Urolithiasis; Young Adult
Settore MED/24 - Urologia
2019
Article (author)
File in questo prodotto:
File Dimensione Formato  
145 sighinolfi2019 (1).pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 841.82 kB
Formato Adobe PDF
841.82 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Sighinolfi2019_Article_Drug-InducedUrolithiasisInPedi.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 824.28 kB
Formato Adobe PDF
824.28 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/876420
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 12
social impact